Edward Michals to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Edward Michals has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.023
-
Delayed response and survival from NovoTTF-100A in recurrent GBM. Med Oncol. 2013 Mar; 30(1):338.
Score: 0.023
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.